NAROPIN 5 mg/ml sol perf 5x10 ml
7680540150064
CH-54015
N01BB09
01.02.2.
1 / 3
google
Details
- GTIN
- 7680540150064
- Pharmacode
- -
- Product number
- 5401504
- CPT
- -
- Packaging group
- 5 x 10
- Unit
- ml
- Composition
- ropivacaini hydrochloridum 5 mg corresp. ropivacainum 4.42 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 3.5 mg.
Articles (1)
Naropin 5 mg/ml, Injektionslösung
Injektionslösung
5 x 10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ropivacaini hydrochloridum
|
5.0 MG | Substance | WIZUS |
|
ropivacainum
|
4.42 MG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 54015
- Drug name
- Naropin, Injektionslösung
- Galenic form
- LSIN
- ATC Code
- N01BB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/02/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 01.02.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NAROPIN 5 mg/ml sol perf 5x10 ml
- Description (DE)
- NAROPIN 5 mg/ml Inf Lös 5x10 ml
- Market launch
- 06/07/2026
- Narcotic (BTM)
- No